Why Better Outcomes Cost Less

Leeza Osipenko and Pramod John

Seminar for Consilium Scientific, an independent non-profit organization improving clinical research through scientific rigor and transparency, 09/14/2023

VIVIO CEO, Pramod John, speaks with UK-based Consilium Scientific.

The paradox: Why can’t we reject high costs and subpar drug quality? Delve into healthcare inefficiencies driving this disparity and explore a pragmatic path to enhance outcomes and cut costs! Why can’t we say ‘No’ to high prices and low drug quality? The United States, which accounts for only 4% of the world’s population, spends as much on drugs as the rest of the world combined. Despite this, health outcomes in the US are often worse than those in developing countries. Economic inefficiencies of the healthcare system are the main drivers of these poor results. By focusing on outcomes and taking a commonsense approach, significant cost savings can be achieved.